Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors

Diabetes Care
Jessica R CastlePeter G Jacobs

Abstract

Automated insulin delivery is the new standard for type 1 diabetes, but exercise-related hypoglycemia remains a challenge. Our aim was to determine whether a dual-hormone closed-loop system using wearable sensors to detect exercise and adjust dosing to reduce exercise-related hypoglycemia would outperform other forms of closed-loop and open-loop therapy. Participants underwent four arms in randomized order: dual-hormone, single-hormone, predictive low glucose suspend, and continuation of current care over 4 outpatient days. Each arm included three moderate-intensity aerobic exercise sessions. The two primary outcomes were percentage of time in hypoglycemia (<70 mg/dL) and in a target range (70-180 mg/dL) assessed across the entire study and from the start of the in-clinic exercise until the next meal. The analysis included 20 adults with type 1 diabetes who completed all arms. The mean time (SD) in hypoglycemia was the lowest with dual-hormone during the exercise period: 3.4% (4.5) vs. 8.3% (12.6) single-hormone (P = 0.009) vs. 7.6% (8.0) predictive low glucose suspend (P < 0.001) vs. 4.3% (6.8) current care where pre-exercise insulin adjustments were allowed (P = 0.49). Time in hypoglycemia was also the lowest with dual-hormon...Continue Reading

Associated Clinical Trials

Aug 11, 2016·Jessica Castle, Jessica Castle

References

Dec 7, 2010·Journal of Diabetes Science and Technology·Gerald J Taborsky
May 20, 2014·IEEE Transactions on Bio-medical Engineering·Peter G JacobsW Kenneth Ward
May 31, 2014·Journal of Diabetes Science and Technology·Kamuran TurksoyAli Cinar
May 23, 2015·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network
Nov 3, 2015·The Journal of Clinical Endocrinology and Metabolism·Ahmad HaidarBruce A Perkins
May 4, 2016·The Lancet. Diabetes & Endocrinology·Ahmad HaidarRémi Rabasa-Lhoret
Jun 22, 2016·Journal of Diabetes Science and Technology·Jessica R CastleSteven Prestrelski
Jun 23, 2016·Diabetes Care·David M MaahsJohn W Lum
Jul 2, 2016·Diabetologia·Hood Thabit, Roman Hovorka
Sep 16, 2016·Diabetes, Obesity & Metabolism·Nadine TalebRémi Rabasa-Lhoret
Oct 18, 2016·Diabetes Technology & Therapeutics·Alex ZhongFrancine R Kaufman
Jan 6, 2017·Diabetes Technology & Therapeutics·Lutz Heinemann, Douglas Muchmore
Jan 28, 2017·The Lancet. Diabetes & Endocrinology·Michael C RiddellLori M Laffel
Aug 29, 2017·Diabetes Technology & Therapeutics·Nadine TalebRémi Rabasa-Lhoret

❮ Previous
Next ❯

Citations

Jul 25, 2018·Pediatric Diabetes·Jennifer L SherrDavid M Maahs
Sep 6, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·C K Boughton, R Hovorka
Feb 2, 2019·Diabetes Technology & Therapeutics·Jessica R Castle, Mikael Elander
Feb 6, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Halis Kaan Akturk, Satish Garg
Jun 4, 2019·Diabetes Technology & Therapeutics·Jessica R Castle, David Rodbard
Feb 21, 2019·Diabetes Technology & Therapeutics·Revital NimriEyal Dassau
Aug 24, 2019·Journal of Diabetes Science and Technology·Leah M WilsonJessica R Castle
Jul 25, 2019·Diabetes Technology & Therapeutics·Ethan ChenDavid C Klonoff
Oct 15, 2019·Journal of Diabetes Science and Technology·Pau HerreroPantelis Georgiou
Oct 1, 2019·American Journal of Therapeutics·M Elena HernandoAgustín Rodríguez-Herrero
Nov 24, 2019·Diabetes/metabolism Research and Reviews·Sarit Polsky, Halis K Akturk
May 10, 2020·Artificial Organs·Chiara Fabris, Boris Kovatchev
Feb 19, 2020·Diabetes Technology & Therapeutics·Melanie Jackson, Jessica R Castle
Feb 26, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·L A DiMeglioUNKNOWN SENCE Study Group
Aug 8, 2018·Biosensors·Shaelyn K Houlder, Jane E Yardley
Aug 31, 2018·Current Diabetes Reports·Vikash DadlaniYogish C Kudva
Aug 4, 2019·Der Internist·Georg SerflingHendrik Lehnert
Oct 22, 2019·Journal of Diabetes Science and Technology·Vanessa MoscardóJorge Bondia
Jul 23, 2020·Nature Metabolism·Nichole S TylerPeter G Jacobs
Dec 14, 2018·Frontiers in Endocrinology·Jane E YardleyRichard M Bracken
Feb 23, 2020·Expert Opinion on Drug Delivery·Klemen Dovc, Tadej Battelino
Jun 11, 2020·Sensors·Nichole S Tyler, Peter G Jacobs
Apr 9, 2020·Expert Opinion on Pharmacotherapy·Shujuan LiLi Wang
Aug 10, 2020·Clinical and Translational Science·Alan GodfreyElena S Izmailova
Jun 14, 2020·Diabetologia·Michael C RiddellRichard M Bracken
Apr 17, 2020·Diabetes Technology & Therapeutics·Clara Mosquera-LopezPeter G Jacobs
May 19, 2020·Minerva pediatrica·Klemen Dovc, Tadej Battelino
Aug 28, 2020·The Journal of Clinical Endocrinology and Metabolism·Clara ViñalsMarga Giménez
Dec 29, 2020·American Journal of Physiology. Endocrinology and Metabolism·Thanh-Tin P NguyenJoseph El Youssef
Jan 8, 2021·Current Nutrition Reports·Melissa J Schoelwer, Mark D DeBoer
Jan 26, 2020·Endocrinology and Metabolism Clinics of North America·Leah M WilsonJessica R Castle
Jan 16, 2021·Sensors·Elena Muñoz FabraAlejandro José Laguna Sanz
Oct 23, 2020·Diabetes/metabolism Research and Reviews·Ajenthen G RanjanKirsten Nørgaard

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02862730

Software Mentioned

STATA
ZephyrLife BioPatch

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.